当前位置: 首页 > 期刊 > 《中国当代医药》 > 2010年第13期 > 正文
编号:12032484
来氟米特对糖尿病肾病大鼠肾脏VEGF表达的影响(3)
http://www.100md.com 2010年5月5日 赵东家,于为民,李荣山
第1页

    参见附件(2723KB,4页)。

     总之,VEGF在DN的发生及发展中起到一定的致病作用。本研究结果证实来氟米特对DN模型的VEGF表达具有一定的调节作用,可以减轻肾脏病变程度及延缓DN向终末期进展,但其具体作用机制有待于进一步研究。

    [参考文献]

    [1] Bates DO,Harper SJ.Regulation of vascular permeability by vascular endothelial growth factors[J].Vascular Pharmacol,2002,39(4-5):225-237.

    [2] Amemiya T,Sasamura H,Mifune M,et al.Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells[J].kidney Int,1999,56(6):2055-2063.

    [3]Wu GJ, Wang H, YU L, et al. Immunosuppressive therapy for renal transplant recipients with cellcept, cyclosporine A and Prednisone[J].China Journal of Modern Medicine,2006,16(17):2640-2642.

    [4]Io H,Hamada C, Ro Y, et al. Morphology changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosisrat models[J].Kidney Int, 2004,65(5):1927-1936.

    [5]Tsilibary E C.Microvascular basement membranes in diabetes mellitus[J].J Pathol,2003,200(4):537-546.

    [6] Gudehithlu KP, Singh AK. Vascular endothelial growth factor and diabetic nephropathy[J].Int JArtif Organs, 1999,22(5)∶297-299.

    [7]Flyvbjerb A. Putative pathophysiological role of growth factors and cytokines in experim ental diabetic kidney disease [J].Diabetologia, 2000,43(10)∶1205-1223.

    [8]De Vriese AS,Tilton RG,Elger M,et al ......

您现在查看是摘要介绍页,详见PDF附件(2723KB,4页)